Free cash flow
Gilead Sciences Free cash flow decreased by 21.2% to $3.12B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.4%, from $2.83B to $3.12B. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -3.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.
cf_free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.20B | $3.11B | $3.05B | $1.59B | $1.66B | $2.71B | $2.39B | $1.64B | $2.20B | $1.63B | $1.95B | $2.11B | $1.20B | $4.17B | $2.83B | $1.65B | $720.00M | $3.96B | $3.12B |
| QoQ Change | — | +41.7% | -2.1% | -47.8% | +4.1% | +63.1% | -11.8% | -31.5% | +34.5% | -25.7% | +19.7% | +8.2% | -43.5% | +248.8% | -32.1% | -41.5% | -56.4% | +450.1% | -21.2% |
| YoY Change | — | — | — | — | -24.5% | -13.1% | -21.7% | +2.6% | +32.5% | -39.7% | -18.1% | +29.3% | -45.7% | +155.2% | +44.7% | -21.8% | -39.7% | -5.0% | +10.4% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's free cash flow?
- Gilead Sciences (GILD) reported free cash flow of $3.12B in Q4 2025.
- How has Gilead Sciences's free cash flow changed year-over-year?
- Gilead Sciences's free cash flow increased by 10.4% year-over-year, from $2.83B to $3.12B.
- What is the long-term trend for Gilead Sciences's free cash flow?
- Over 4 years (2021 to 2025), Gilead Sciences's free cash flow has grown at a -3.3% compound annual growth rate (CAGR), from $10.81B to $9.46B.
- What does free cash flow mean?
- The cash a company has left over after paying for its operating expenses and capital investments.